Memory-Enhancing Effects of Daidzin, Possibly Through Dopaminergic and AChEergic Dependent Pathways
Muhammad Torequl Islam1, Abdullah Al Shamsh Prottay2, Md Shimul Bhuia2
1Pharmacy Discipline, Khulna University, Khulna 9208, Bangladesh; Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
Background:
The soy isoflavone daidzin (DZN) possesses cognitive-enhancing effects in animals.
Objectives:
However, the mechanism for this effect is yet to be discovered.
Methods:
For this, we investigate its memory-enhancing capacity using the mouse models of marble burying, dust removal, an open-field study, and in silico studies. Adult male Swiss albino mice were randomly assigned to different groups consisting of control (vehicle: 10 mL/kg), DZN 5, 10, and 20 mg/kg, dopamine (agonist: 22 mg/kg), galantamine (inhibitor: 3 mg/kg), and a combination of DZN-10 with standards.
Results:
DZN dose-dependently and significantly (P < 0.05) increased marble burying and removed dust while decreasing the total distance in the open-field test (OFT). DZN-10 enhanced dopamine's effect significantly (P < 0.05). In silico findings suggest that DZN has strong binding capacities of -10.3, -7.5, -9.8, and -9.2 kcal/mol to the acetylcholinesterase (AChE), D1, D3, and D5 receptors, respectively.
Conclusions:
Taken together, DZN may exert its memory-enhancing ability by interacting with AChE and dopamine receptors.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Synthesis
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...


